Printer Friendly

Printed from http://www.researchandmarkets.com/reports/1382365

Tinea Pedis (Athletes Foot) - Global Strategic Business Report

Description:
This report analyzes the US market for Tinea Pedis (Athletes Foot) in US$ Million. Annual estimates and forecasts are provided for the period of 2006 through 2015. The report profiles 43 companies including many key and niche players such as Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson, Kaken Pharmaceutical Co., Ltd., Merck & Co., Inc., Nitric BioTherapeutics, Inc., Novartis AG, Sanofi-Aventis, Stiefel Laboratories, Inc., and Topica Pharmaceuticals, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.


Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.

For information on site licence pricing please click on Enquire before buying
 
Contents:
TINEA PEDIS (ATHLETE'S FOOT)
A US MARKET REPORT


CONTENTS


I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-3
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3


II. A US MARKET REPORT

1. INDUSTRY OVERVIEW II-1
A Curtain Raiser II-1
Distribution and Prevalence of Tinea Pedis II-1
Table 1: Global Tinea Pedis (Athletes Foot) Market (2009E):
Percentage Breakdown of Global Prevalence of Fungal
Infections of the Skin by Country - France, Germany, Italy,
UK, US, and Japan (includes corresponding Graph/Chart) II-2
Statistical Insights II-2
Foot Facts & Figures II-2
Current and Future Analysis II-3
Table 2: US Recent Past, Current and Future Analysis for
Tinea Pedis (Athlete's Foot) with Annual Sales Figures in US$
Million for Years 2006 through 2015 (includes corresponding
Graph/Chart) II-3
Market Dynamics II-3
Introduction of Novel Formulations Spurs Demand II-3
Aging Population Revs up Anti-Fungal Market II-4
Table 3: US Population by Age Group: 2010E (includes
corresponding Graph/Chart) II-4
Market Challenges II-4
Time Consuming Clinical Trials Stall Growth II-4
Table 4: Tinea Pedis (Athletes Foot) Products by
Different Phases of Development (2009) - Marketed Products,
Discontinued Projects, Phase I Trials, Phase II Trials, and
Under Development (includes corresponding Graph/Chart) II-5
Low Levels of Patient Compliance Reduces Revenue Potential II-5
Lack of Public Awareness Prevents Market Growth II-5
Key Statistical Findings II-6
Table 5: Global Dermatology Market (2009) - Number of
Marketed and Pipeline Products in Phase I, II and III
Globally Available By Indication - Skin Infections, Skin
Disorders, Acne, Skincare, Wounds, and Tinea Pedis (includes
corresponding Graph/Chart) II-6

Table 6: Global Tinea Pedis (Athletes Foot) Market (2009):
Number of Available Marketed Products for Tinea Pedis
(Athletes Foot) by Company - Hisamitsu Pharmaceutical Co.,
Inc., Johnson & Johnson, Kobayashi Pharmaceutical Co., Ltd.,
Novartis AG, and Taisho Pharmaceutical Co., Ltd. (includes
corresponding Graph/Chart) II-7

2. AN OVERVIEW OF TINEA PEDIS (ATHLETES FOOT) II-8
An Introduction II-8
Types II-8
Moccasin Tinea Pedis II-8
Interdigital Tinea Pedis II-8
Inflammatory or Bullous Tinea Pedis II-8
Contagious Nature of the Disease II-8
Person to Person II-8
Transmission to Other Body Parts II-9
Object to Person II-9
Animal to Person II-9
Causes of Foot Rashes II-9
Symptoms II-9
Diagnosis II-10
Importance of Timely Diagnosis II-10
Preventive Measures II-11
At Home II-11
At Public Places II-11
Personal Preventive Measures II-11
Treatments II-12
Traditional Treatment II-12
Topical Medications II-12
Oral Medications II-13
Identifying Optimal Formulation II-13
Alternative Treatment II-13
Treatment Process II-14
Complications II-15
Conclusion II-15

3. SELECT DRUGS AVAILABLE FOR TINEA PEDIS II-16
Oral and Topical Agents for Tinea Pedis II-16
Select Anti-Fungal OTC and Prescription Drugs Available by the
Mechanism of Action II-17
Review of Select Treatments II-17
Ertaczo (Sertaconazole Nitrate) II-17
Lamisil® (Terbinafine) II-18
Lotrimin Ultra (Butenafine) II-18
Naftin (Naftifine Hydrochloride) II-18
Oxistat (Oxiconazole Nitrate) II-19
Penlac® II-19

4. RESEARCH AND DEVELOPMENT II-20
Clinical Trials II-20
Nitric BioTherapeutics Starts Phase II Onychomycosis Study II-20
Topica Pharmaceuticals Begins Phase 2 Clinical Trial of
Luliconazole II-20
Other Research & Development Initiatives II-21

5. RECENT INDUSTRY ACTIVITY II-22
Sanofi Acquires Chattem II-22
Topica Pharmaceuticals Gets FDA Approval for Luliconazole IND
(US) II-22
Nitric BioTherapeutics Purchase New Technology Platform and
Advanced Clinical Programs II-22
Ranbaxy Laboratories Introduces Lulifin (India) II-23
Schering-Plough Launches Tinactin Chill II-23
Paddock Laboratories Receives FDA Approval for Ciclopirox Gel II-23
Peng Lai Jin Chuang Pharmaceutical Receives Production
Approval from SFDA (China) II-24

6. FOCUS ON KEY PLAYERS II-25
Hisamitsu Pharmaceutical Co., Inc. (Japan) II-25
Johnson & Johnson (US) II-25
Kaken Pharmaceutical Co., Ltd. (Japan) II-25
Merck & Co., Inc. (US) II-26
Nitric BioTherapeutics, Inc. (US) II-26
Novartis AG (Switzerland) II-26
Sanofi-Aventis (France) II-27
Stiefel Laboratories, Inc. (US) II-27
Topica Pharmaceuticals, Inc. (US) II-27


III. COMPETITIVE LANDSCAPE

Total Companies Profiled: 43 (including Divisions/Subsidiaries - 50)

---------
Region/Country Players
---------
The United States 17
Japan 6
Europe 10
France 1
Germany 2
The United Kingdom 2
Spain 1
Rest of Europe 4
Asia-Pacific (Excluding Japan) 10
Latin America 1
Africa 2
Middle-East 4
---------
 
Ordering:
Order Online - visit http://www.researchandmarkets.com/reports/1382365

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

 
Page 1 of 2
Printed Jul 31th 2014
9:26:22 AM

Fax order form

To place a fax order simply print this form, fill in and fax the completed form to the number below. If you have any questions please email help@researchandmarkets.net

Order information

Please verify that the product information is correct and select the format you require.

Product name

Tinea Pedis (Athletes Foot) - Global Strategic Business Report

Web Address

http://www.researchandmarkets.com/reports/1382365

Office Code

OC8DIMOSTSPVTV

 

Report Formats

Please enter the quantity of the report format you require.

Format Quantity Price
Hard Copy USD 3,450 + USD 68 Shipping/Handling *
Electronic (PDF) - Single User USD 3,450
Electronic (PDF) - 1 - 5 Users USD 4,830
Electronic (PDF) - 1 - 15 Users USD 8,280
Electronic (PDF) - 1 - 10 Users USD 6,555

* Shipping/Handling is only charged once per order.

Contact information

Please enter all the information below in block capitals.

Title:
Mr Mrs Dr Miss Ms Prof
First Name:
Last Name:
Email Address:
Job Title:
Organisation:
Address:
City:
Postal / Zip Code:
Country:
Phone Number:
Fax Number:

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Page 2 of 2
Printed Jul 31th 2014
9:26:22 AM

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

Pay by Credit Card:

American Express

Diners Club

Master Card

Visa

Cardholder's Name:
Cardholder's Signature:
Expiry Date:
/
Card Number:
CVV Security Code:
Issue date:
/ (Diners Club only)
 
Pay by Check:

Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

 
Pay by Wire Transfer:

Please transfer funds to:

Account Number:
83313083
Sort Code:
98-53-30
Swift Code:
ULSBIE2D
IBAN Number:
IE78ULSB98533083313083
Bank Address:
Ulster Bank,
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.
 

If you have a Marketing Code please enter it below:

Marketing Code:

Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)